A condition previously known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). The name change is intended to improve diagnosis and care for the condition, which affects a large number of women worldwide. The renaming is the result of a collaborative effort involving health professionals and patients, and is seen as a potential step towards better understanding and treatment of the condition.